Positive Results From Human PK Study Assessing Orexo's New Intranasal Naloxone Formulations for Opioid Overdose Reversal

Corporate Breaking News

Home : Positive Results From Human PK Study Assessing Orexo's New Intranasal Naloxone Formulations for Opioid Overdose Reversal

Jan 07 2019	Positive Results From Human PK Study Assessing Orexo's New Intranasal Naloxone Formulations for Opioid Overdose Reversal
UPPSALA, Sweden, Jan. 7, 2019 /PRNewswire/ -- Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces positive results from the human pharmacokinetic (PK) study OX124-001 in 20 healthy volunteers, assessing Orexo's novel ...


Source:https://www.prnewswire.com:443/news-releases/positive-results-from-human-pk-study-assessing-orexos-new-intranasal-naloxone-formulations-for-opioid-overdose-reversal-300773591.html

Related News
» Hexagon Strengthens Smart Factory Position With Autonomous Production Technologies From Etalon » No More Power gap: myFC Shows its Smartphone Integration Offering LAMINA MAX at CES in Las Vegas